SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Home Health Care Management & Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cuthrell, P. J.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Safe Medical Devices Act: Impact on a hospital-based home infusion agency

Paula J. Cuthrell

Home Health Care Children's Hospital Medical Center Cincinnati, Ohio

The Safe Medical Devices Act (SMDA) was signed by President George Bush on November 28, 1990, and the Federal Drug Administration's (FDA's) final ruling became effective on August 29, 1993. This act has brought about significant changes in the regulation and reporting process of medical devices within the health care industry over the past 3 years. This law has altered the structure of medical device regulatory mechanisms, and it has expanded the scope of the FDA's practice to enforce the provisions. Not only has the SMDA placed a great burden on companies that develop, produce, and distribute medical technology, but it has directly affected the hospi tals and health care facilities that use medical devices. Implementation of the current FDA regu lations for medical device tracking imposes a great deal of pressure on hospital-based home infusion therapy agencies. In order to comply with the regulations, hospital-based home infu sion agencies must develop a clear, concise system for tracking infusion pumps. These agencies must also incorporate a teaching module for all staff to become better informed on device mal function reporting. Key words: home health care, infusion pumps, Safe Medical Devices Act

Home Health Care Management & Practice, Vol. 7, No. 1, 41-46 (1994)
DOI: 10.1177/108482239400700110


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement